Brad Partridge

Dr Brad Partridge has been a researcher in hospitals and universities for almost 20 years. His work has covered ethical, social, and policy issues related to a range of topics in healthcare including addiction, concussion management, psychiatry, midwifery, and biomedical enhancement technologies. He has written about conflicts of interest, medicalisation, and stakeholder attitudes towards models of treatment, and has extensive experience using qualitative research methods.

Brad joined the UQ Business School in April 2023 where he is exploring trust, and the attitudes of clinicians, towards incorporating Artificial Intelligence (AI) tools into the clinical decision-making process for melanoma detection, as part of an NHMRC Synergy Grant.

Brad was previously a postdoctoral research fellow in biomedical ethics at Mayo Clinic (Minnesota, USA), and was a visiting research fellow with the Neuroethics Research Group at the Montreal Clinical Research Institute (IRCM), in Canada. From 2011-2014 he was an NHMRC postdoctoral fellow with the addiction neuroethics group led by Prof. Wayne Hall at the University of Queensland Centre for Clinical Research (UQCCR). There, he was a Chief Investigator on two ARC Discovery Grants related to 1) the non-medical use of prescription stimulants, and 2) the ethical, social and policy implications of neurobiological explanations of addiction. Between 2015-2023 he held research in public hospitals within Metro-North Hospital and Health Service (Queensland Health), and at the Queensland Centre for Mental Health Research (QCMHR).

Brad’s PhD was from the University of Queensland School of Public Health. He also has a Master of Arts in Philosophy, and Bachelor of Psychology (Hons) from the University of New England.